Filing Details
- Accession Number:
- 0001144204-11-056887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-06 20:34:39
- Reporting Period:
- 2011-10-04
- Filing Date:
- 2011-10-06
- Accepted Time:
- 2011-10-06 20:34:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1137883 | Brainstorm Cell Therapeutics Inc | BCLI | Biological Products, (No Disgnostic Substances) (2836) | 912061050 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197981 | L G Robert Shorr | C/O Brainstorm Cell Therapeutics Inc., 605 Third Avenue, 34Th Floor New York NY 10158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-10-04 | 105,000 | $0.31 | 433,333 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-10-05 | 95,000 | $0.30 | 338,333 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transaction was executed in multiple trades at prices ranging from $0.31 to $0.314. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades at prices ranging from $0.30 to $0.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
